Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,026–5,050 of 27,380 studies, newest first · page 202 of 1096.

March 2025 25

  1. 2025-03-05

    [Glucagon-like peptide-1 receptor agonists: a new pharmacological treatment option for psychiatric illnesses?]

    ✓ Peer-reviewed Drug development Der Nervenarzt

    Key finding: More severe side effects include pancreatitis, allergic reactions, renal function disorders and possibly an increased risk of thyroid cancer.

  2. 2025-03-05

    Blood Biomarkers Reflect Dementia Symptoms and Are Influenced by Cerebrovascular Lesions

    ✓ Peer-reviewed Biomarkers International journal of molecular sciences

    Key finding: Bivariate analysis exhibited that all measured BM indicators were significantly associated with cognitive decline in patients without past stroke lesions. +2 more findings

  3. 2025-03-05

    Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis

    ✓ Peer-reviewed Biomarkers Nature communications

    Key finding: Serum p-tau 181 and p-tau 217 were higher in AD and ALS patients compared to disease controls. +1 more finding

  4. 2025-03-05
  5. 2025-03-05

    Unmet Activities of Daily Living (ADL) Care Needs and Associated Risk Factors Among Older Adults with Dementia at the End of Life

    ✓ Peer-reviewed End-of-life care Journal of Gerontological Social Work

    Key finding: This paper examined the prevalence of and risk factors associated with unmet needs for activities of daily living (ADL) for older adults dying with dementia. +1 more finding

  6. 2025-03-05

    Unlocking Cognitive Potential: Exploring a Virtual Environment for Cognitive Training in Healthy Aging and Mild Cognitive Impairment

    ✓ Peer-reviewed Prevention trials IRBM

    Key finding: Participants with MCI exhibited a significantly higher frequency of wandering and uncorrected orientation errors, compared to cognitively healthy older adults. +1 more finding

  7. 2025-03-05

    The interplay between age at menopause and synaptic integrity on Alzheimer’s disease risk in women

    ✓ Peer-reviewed Disease mechanisms Science Advances

    Key finding: Earlier estrogen depletion-via earlier menopause-has been associated with increased risk for Alzheimer's disease (AD). +3 more findings

  8. 2025-03-05

    Sinomenine alleviates neuroinflammation in chronic cerebral hypoperfusion by promoting M2 microglial polarization and inhibiting neuronal pyroptosis via exosomal miRNA-223-3p

    ✓ Peer-reviewed Inflammation and the immune system Acta Neuropathologica Communications

    Key finding: Sinomenine (SINO), a natural alkaloid derived from traditional Chinese medicine, has shown significant anti-inflammatory and neuroprotective properties. +4 more findings

  9. 2025-03-05

    Assessing Co‐Localization of ITM2B With Alzheimer's Disease and Limbic‐Predominant Age‐Related TDP ‐43 Encephalopathy Neuropathologic Changes

    ✓ Peer-reviewed Brain tissue and pathology Neuropathology

    Key finding: Mutations in the Integral membrane protein 2B (ITM2B) gene are linked to the development of familial British and Danish dementias, two relatively early-onset dementia disorders known also to be associated with Tau neurofibrillary tangles (NFTs). +1 more finding

  10. 2025-03-05

    The Effect of Hypertension on Cognitive Decline and Dementia: A Meta- Analysis

    ✓ Peer-reviewed Risk factors Cardiology and Cardiovascular Medicine

    Key finding: According to studies regarding hypertension, patients suffering from it showed a much higher risk score (38%) of cognitive impairment than normotensives. +2 more findings

  11. 2025-03-05

    EEG-Based Dementia Classification Using CS-EMD Synchrony Features and Quantum Machine Learning

    ✓ Peer-reviewed Digital health tools IEEE Transactions on Consumer Electronics

    Key finding: On the other hand, quantum machine learning (QML), which combines the concepts of quantum computing and machine learning, has recently gained much attention with the rising anticipation that this emerging research field may provide significant advantages over classical methods. +1 more finding

  12. 2025-03-05

    Assessing Cognition Remotely: Expanding the Reach of Cognitive Testing for Older Adults at Risk for Dementia in a Randomized Controlled Trial

    ✓ Peer-reviewed Getting a diagnosis Canadian Geriatrics Journal

    Key finding: Scores on the MoCA (p=.076), CFC2 (p=.053), and T-CogS (p=.281) were not statistically significantly different from baseline to post-intervention.

  13. 2025-03-05

    Correlation of magnetic resonance imaging parameters with montreal cognitive assessment-Indonesian (MOCA-INA) score in dementia patients at Prof. Dr. IGNG Ngoerah General Hospital, Denpasar, Bali, Indonesia

    ✓ Peer-reviewed Getting a diagnosis The Egyptian Journal of Radiology and Nuclear Medicine

    Key finding: Parameters such as clinical status, GCA scale, MTA scale, Fazekas scale, strategic infarction, Koedam score, stroke, hypertension, diabetes mellitus, dyslipidemia, and cardiovascular disease do not have significant correlations with MoCA-INA scores. +3 more findings

  14. 2025-03-05

    Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage

    ✓ Peer-reviewed Prevention and risk JAMA Surgery

    Key finding: Among 1136 patients in the intention-to-treat population, 526 (46.3%) were female and 610 (53.7%) male; they had a mean (SD) age of 70 (11) years, body mass index of 28 (5), and age-adjusted Charlson Comorbidity Index of 5 (3). +4 more findings

  15. 2025-03-05

    Cardiovascular diseases and risk of dementia in the general population

    ✓ Peer-reviewed Prevention and risk European Journal of Preventive Cardiology

    Key finding: Observationally, CVDs were associated with risk of all incident outcomes in meta-analyses, with hazard ratios up to 7.00 (95% confidence interval [CI]: 6.20, 7.92). +4 more findings

  16. 2025-03-05

    Plasma NfL, P-tau181, and P-tau181/Aβ42 Ratio in Predicting Mild Behavioral Impairment in Dementia-Free Multiethnic Asian Older Adults With Mixed Pathology in a 5-Year Clinical Cohort

    ✓ Peer-reviewed Tau biomarkers The Journal of clinical psychiatry

    Key finding: The underlying mechanisms of mild behavioral impairment (MBI), a marker for cognitive impairment and dementia, have remained unclear especially in a multiethnic Asian population. +3 more findings

  17. 2025-03-04

    Autophagy regulates cellular senescence by mediating the degradation of CDKN1A/p21 and CDKN2A/p16 through SQSTM1/p62-mediated selective autophagy in myxomatous mitral valve degeneration

    ✓ Peer-reviewed Disease mechanisms Autophagy

    Key finding: In the present study, we found senescent aVICs exhibited impaired macroautophagy/autophagy as evidenced by compromised autophagy flux and immature autophagosomes. +1 more finding

  18. 2025-03-04

    Structural variants linked to Alzheimer's disease and other common age-related clinical and neuropathologic traits

    ✓ Peer-reviewed Genetics Genome medicine

    Key finding: First, we mapped SVs across 81 AD risk loci and discovered 22 SVs in linkage disequilibrium (LD) with GWAS lead variants and directly associated with the phenotypes tested. +4 more findings

  19. 2025-03-04

    Hospice Use Among Medicare Beneficiaries With Parkinson Disease and Dementia With Lewy Bodies

    ✓ Peer-reviewed Lewy body dementia JAMA Network Open

    Key finding: Of 11 327 324 Medicare beneficiaries enrolled in hospice between 2010 and 2020 who met eligibility criteria (mean [SD] age, 85.2 [7.5] years; 781 763 [63.0%] female), there were 958 182 (8.4%) with a primary diagnosis of AD, 232 864 (2.1%) with PD, and 49 340 (0.4%) with DLB. +4 more findings

  20. 2025-03-04

    Confounder adjustment in observational studies investigating multiple risk factors: a methodological study

    ✓ Peer-reviewed Risk factors BMC Medicine

    Key finding: A total of 162 studies were included, with 88 (54.3%) exploring potential risk factors and 74 (45.7%) examining specific risk factors. +4 more findings

  21. 2025-03-04
  22. 2025-03-04

    Cardiovascular-kidney-metabolic syndrome and incidence of dementia among older adults

    ✓ Peer-reviewed Getting a diagnosis The Journal of Prevention of Alzheimer s Disease

    Key finding: The 2,641 participants had a mean (SD) age of 74 (2.8) years at baseline; 53 % were female, 36 % were of Black race, and had a range of baseline CKM: 3 % Stage 0 (no CKM), 4 % Stage 1 (excess/dysfunctional adiposity), 26 % Stage 2 (metabolic risk factors), 24 % Stage 3 (subclinical CVD and CKD), and 43 % Stage 4 (clinical CVD and CKD). +4 more findings

  23. 2025-03-04

    Long‐Term Exposure to Non‐Steroidal Anti‐Inflammatory Medication in Relation to Dementia Risk

    ✓ Peer-reviewed Prevention and risk Journal of the American Geriatrics Society

    Key finding: During an average follow-up period of 14.5 years, a total of 9520 (81.1%) participants had used NSAIDs at any given time, and 2091 participants developed dementia. +4 more findings

  24. 2025-03-03

    Lecanemab for mild Alzheimer disease - is there a way forward?

    ✓ Peer-reviewed Treatments Drugs in context

    Key finding: This Editorial reviews data on the efficacy and adverse effects of lecanemab amongst individuals with mild Alzheimer disease. +2 more findings

  25. 2025-03-03

    Developing a best-practice guide to support care for Aboriginal and Torres Strait Islander peoples living with cognitive impairment and dementia: Prioritising inclusivity, consensus-building and cultural values

    ✓ Peer-reviewed End-of-life care SSM - Mental Health

    Key finding: Stakeholders wanted a BPG that was: comprehensive, easy to follow and practical; incorporated cultural considerations and took account of the ongoing effects of colonisation. +4 more findings

Browse the library by subject, with the full score breakdown →